Form 4: REGENXBIO Director Karabelas Exercises Options and Sells Shares

Director Argeris N. Karabelas exercised stock options and sold shares of REGENXBIO Inc. on July 29, 2024, according to a Form 4 filing.

Summary

• On July 29, 2024, Argeris N. Karabelas, a director of REGENXBIO Inc., exercised stock options to acquire 11,000 shares of common stock at a price of $12.74 per share.
• Simultaneously, Karabelas sold 11,000 shares of common stock at a weighted average price of $15.045, with individual sales ranging from $15.00 to $15.32.
• Following these transactions, Karabelas directly owns 11,286 shares of REGENXBIO Inc.
• The option exercised was part of a previously granted option for 12,500 shares, which vested in 12 equal monthly installments starting June 1, 2016.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions were pre-planned under a 10b5-1 trading plan. The director exercised options and sold shares, which is a common practice.

Positives

• The exercise of options and subsequent sale suggests the director is taking advantage of the current stock price.

Industry Context

Insider transactions are common, and closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. A pre-planned sale under Rule 10b5-1 is less likely to be interpreted as a reaction to immediate company news.

Key Dates